These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 1650143)
1. Vasopressin receptor-mediated endocytosis: current view. Lutz W; Salisbury JL; Kumar R Am J Physiol; 1991 Jul; 261(1 Pt 2):F1-13. PubMed ID: 1650143 [TBL] [Abstract][Full Text] [Related]
2. Internalization of vasopressin analogs in kidney and smooth muscle cells: evidence for receptor-mediated endocytosis in cells with V2 or V1 receptors. Lutz W; Sanders M; Salisbury J; Kumar R Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6507-11. PubMed ID: 2144348 [TBL] [Abstract][Full Text] [Related]
3. Internalization of V2-vasopressin receptors in LLC-PK1-cells: evidence for receptor-mediated endocytosis. Hocher B; Merker HJ; Dürr JA; Schiller S; Gross P; Hensen J Biochem Biophys Res Commun; 1992 Aug; 186(3):1376-83. PubMed ID: 1387309 [TBL] [Abstract][Full Text] [Related]
4. A vasopressin analog that binds but does not activate V1 or V2 vasopressin receptors is not internalized into cells that express V1 or V2 receptors. Lutz W; Londowski JM; Sanders M; Salisbury J; Kumar R J Biol Chem; 1992 Jan; 267(2):1109-15. PubMed ID: 1309761 [TBL] [Abstract][Full Text] [Related]
5. Aquaporin 2 (AQP2) and vasopressin type 2 receptor (V2R) endocytosis in kidney epithelial cells: AQP2 is located in 'endocytosis-resistant' membrane domains after vasopressin treatment. Bouley R; Hawthorn G; Russo LM; Lin HY; Ausiello DA; Brown D Biol Cell; 2006 Apr; 98(4):215-32. PubMed ID: 16563128 [TBL] [Abstract][Full Text] [Related]
6. Functional role of the NPxxY motif in internalization of the type 2 vasopressin receptor in LLC-PK1 cells. Bouley R; Sun TX; Chenard M; McLaughlin M; McKee M; Lin HY; Brown D; Ausiello DA Am J Physiol Cell Physiol; 2003 Oct; 285(4):C750-62. PubMed ID: 12801889 [TBL] [Abstract][Full Text] [Related]
8. cAMP-dependent protein kinase activation affects vasopressin V2-receptor number and internalization in LLC-PK1 renal epithelial cells. Jans DA; Hemmings BA FEBS Lett; 1991 Apr; 281(1-2):267-71. PubMed ID: 1707831 [TBL] [Abstract][Full Text] [Related]
9. Complementation between LLC-PK1 mutants affected in polypeptide hormone-receptor function. Jans DA; Resink TJ; Hemmings BA Eur J Biochem; 1987 Feb; 162(3):571-6. PubMed ID: 3030741 [TBL] [Abstract][Full Text] [Related]
10. Monensin-resistant LLC-PK1 cell mutants are affected in recycling of the adenylate cyclase-stimulating vasopressin V2-receptor. Jans DA; Jans P; Luzius H; Fahrenholz F Mol Cell Endocrinol; 1991 Oct; 81(1-3):165-74. PubMed ID: 1797584 [TBL] [Abstract][Full Text] [Related]
11. Vasopressin increases cytosolic free calcium in LLC-PK1 cells through a V1-receptor. Burnatowska-Hledin MA; Spielman WS Am J Physiol; 1987 Aug; 253(2 Pt 2):F328-32. PubMed ID: 2956892 [TBL] [Abstract][Full Text] [Related]
12. The adenylate cyclase-coupled vasopressin V2-receptor is highly laterally mobile in membranes of LLC-PK1 renal epithelial cells at physiological temperature. Jans DA; Peters R; Zsigo J; Fahrenholz F EMBO J; 1989 Sep; 8(9):2481-8. PubMed ID: 2531084 [TBL] [Abstract][Full Text] [Related]
13. Vasopressin V2-receptor mobile fraction and ligand-dependent adenylate cyclase activity are directly correlated in LLC-PK1 renal epithelial cells. Jans DA; Peters R; Jans P; Fahrenholz F J Cell Biol; 1991 Jul; 114(1):53-60. PubMed ID: 1646825 [TBL] [Abstract][Full Text] [Related]
14. Biotinyl analogues of vasopressin as biologically active probes for vasopressin receptor expression in cultured cells. Jans DA; Bergmann L; Peters R; Fahrenholz F J Biol Chem; 1990 Aug; 265(24):14599-605. PubMed ID: 2143764 [TBL] [Abstract][Full Text] [Related]
15. Oxytocin induces a transient increase in cytosolic free [Ca2+] in renal tubular epithelial cells: evidence for oxytocin receptors on LLC-PK1 cells. Stassen FL; Heckman G; Schmidt D; Papadopoulos MT; Nambi P; Sarau H; Aiyar N; Gellai M; Kinter L Mol Pharmacol; 1988 Feb; 33(2):218-24. PubMed ID: 2828915 [TBL] [Abstract][Full Text] [Related]
16. Vasopressin receptor-mediated endocytosis in cells transfected with V1-type vasopressin receptors. Lutz W; Sanders M; Salisbury J; Lolait S; O'Carroll AM; Kumar R Kidney Int; 1993 Apr; 43(4):845-52. PubMed ID: 8479120 [TBL] [Abstract][Full Text] [Related]
17. Interaction between V1 and V2 effects in hemodynamic response to vasopressin in dogs. Liard JF Am J Physiol; 1990 Feb; 258(2 Pt 2):H482-9. PubMed ID: 2137987 [TBL] [Abstract][Full Text] [Related]
18. Iodination of vasopressin analogues with agonistic and antagonistic properties: effects on biological properties and affinity for vascular and renal vasopressin receptors. Jard S; Lombard C; Seyer R; Aumelas A; Manning M; Sawyer WH Mol Pharmacol; 1987 Sep; 32(3):369-75. PubMed ID: 2959851 [TBL] [Abstract][Full Text] [Related]
19. Ammonium chloride affects receptor number and lateral mobility of the vasopressin V2-type receptor in the plasma membrane of LLC-PK1 renal epithelial cells: role of the cytoskeleton. Jans DA; Peters R; Jans P; Fahrenholz F Exp Cell Res; 1990 Nov; 191(1):121-8. PubMed ID: 2146138 [TBL] [Abstract][Full Text] [Related]
20. Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis. Jard S; Gaillard RC; Guillon G; Marie J; Schoenenberg P; Muller AF; Manning M; Sawyer WH Mol Pharmacol; 1986 Aug; 30(2):171-7. PubMed ID: 3016500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]